BTMD
biote Corp. · Healthcare
Insiders bought $202K of biote Corp. in the last 12 months
1 insider bought on 1 day.
BTMD over the last year
Largest buyers, last 12 months
BTMD after insider buys
3 months after each buy, from the first price a copier could get.
10 buys since 2023 with 3 months of prices.
Every filing
22 insider filings since 2023, newest first
Marc D Beer · Executive Chair
Guines LLC · 10% owner
Guines LLC · 10% owner
Guines LLC · 10% owner
Guines LLC · 10% owner
Guines LLC · 10% owner
Guines LLC · 10% owner
Andrew R Heyer · Director
Bret Christensen · CEO
Stephen Mark Cone · Director
Marc D Beer · Director
Robert Charles Peterson · CFO
Robert Charles Peterson · CFO
Mary Elizabeth Conlon · General Counsel
Mary Elizabeth Conlon · General Counsel
Roystone Capital Management LP · 10% owner
Andrew R Heyer · Director
Samar Jagat Kamdar · CFO
Debra L Morris · Director
Stephen Mark Cone · Director
Marc D Beer · Director
Teresa Sue Weber · CEO
About biote Corp.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.